T
Description
Integrated biopharmaceutical contractor with three lines: early research, cell culture media at thousand-tonne scale, and biologics development and manufacturing. It works with recombinant proteins, antibodies, conjugates, vaccines and cell therapy, and reports over five hundred customers. It runs plants in Nantong, Lanzhou, Shanghai and South Korea. Founded in 2011. Despite the name, it is Chinese rather than American.